Chugai Pharmaceutical Co Ltd (CHGCY)
20.69
+0.21
(+1.03%)
USD |
OTCM |
Nov 21, 16:00
Chugai Pharmaceutical Total Liabilities (Quarterly): 1.917B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 1.917B |
March 31, 2024 | 1.690B |
December 31, 2023 | 2.177B |
September 30, 2023 | 1.892B |
June 30, 2023 | 2.198B |
March 31, 2023 | 2.515B |
December 31, 2022 | 3.397B |
September 30, 2022 | 2.715B |
June 30, 2022 | 2.330B |
March 31, 2022 | 2.822B |
December 31, 2021 | 3.047B |
September 30, 2021 | 2.347B |
June 30, 2021 | 2.024B |
March 31, 2021 | 1.469B |
December 31, 2020 | 2.477B |
September 30, 2020 | 1.995B |
June 30, 2020 | 1.545B |
March 31, 2020 | 1.772B |
December 31, 2019 | 1.882B |
September 30, 2019 | 1.966B |
June 30, 2019 | 1.802B |
March 31, 2019 | 1.549B |
December 31, 2018 | 1.477B |
September 30, 2018 | 1.330B |
June 30, 2018 | 1.282B |
Date | Value |
---|---|
March 31, 2018 | 1.332B |
December 31, 2017 | 1.415B |
September 30, 2017 | 1.275B |
June 30, 2017 | 1.370B |
March 31, 2017 | 1.345B |
December 31, 2016 | 1.374B |
September 30, 2016 | 1.370B |
June 30, 2016 | 1.337B |
March 31, 2016 | 1.269B |
December 31, 2015 | 1.329B |
September 30, 2015 | 1.155B |
June 30, 2015 | 1.067B |
March 31, 2015 | 1.102B |
December 31, 2014 | 1.187B |
September 30, 2014 | 1.190B |
June 30, 2014 | 1.210B |
March 31, 2014 | 1.207B |
December 31, 2013 | 1.182B |
September 30, 2013 | 1.223B |
June 30, 2013 | 1.073B |
March 31, 2013 | 1.084B |
December 31, 2012 | 1.351B |
September 30, 2012 | 983.85M |
June 30, 2012 | 917.25M |
March 31, 2012 | 871.34M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.469B
Minimum
Mar 2021
3.397B
Maximum
Dec 2022
2.222B
Average
2.177B
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 53.58B |
Nxera Pharma Co Ltd | 543.75M |
PeptiDream Inc | 230.61M |
Healios KK | 90.39M |
AnGes Inc | 13.66M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.80B |
Shareholders Equity (Quarterly) | 10.89B |
Current Ratio | 5.087 |